Health and Fitness Health and Fitness
Fri, March 13, 2009
[ 01:07 PM ] - Market Wire
Bennett Environmental Inc.: Bennett Environmental .. Reports Fourth Quarter and 2008 Year End Results
[ 12:49 PM ] - Market Wire
SCOR: Standard & Poor's upgrades SCOR to "A"
[ 10:43 AM ] - Market Wire
Molecular Insight Pharmaceuticals, Inc. : Molecul .. nc. to Announce Fourth Quarter, Year-End 2008 Fin
[ 08:29 AM ] - Market Wire
San Anton Resource Corporation: San Anton Announces Kings Minerals Share Purchase Plan Offer
[ 06:29 AM ] - Market Wire
Lpath, Inc.: Lpath to Hire Clinical Head
[ 03:00 AM ] - Market Wire
MoneyTV; Hydrogen Hybrid Corporation; AlphaTrade. .. ; Cord Blood America, Inc.: MoneyTV, Week of 3/13
Thu, March 12, 2009
[ 07:53 PM ] - Market Wire
Pacific Energy Resources Ltd.: Court Enters Order .. Trading in Stock of Pacific Energy Resources Ltd.
[ 02:05 PM ] - Market Wire
AspenBio Pharma, Inc.: AspenBio Pharma to Proceed With FDA 510(k) Application for AppyScore(TM)
[ 07:20 AM ] - Market Wire
Harte Gold Corp.: Harte Gold Corp. Corporate Update
[ 07:00 AM ] - Market Wire
Sanguine Corporation: Sanguine Corp Announces Let .. mmitment to License PHER-O2 to Rockland Technimed
[ 06:36 AM ] - Market Wire
Pacific Energy Resources Ltd.: TSX Suspends Trading; Subsequent Delisting
[ 06:30 AM ] - Market Wire
AspenBio Pharma, Inc.: AspenBio Pharma to Host Investor Update Call Today at 4:30 PM ET
[ 06:29 AM ] - Market Wire
Urigen Pharmaceuticals: Urigen Pharmaceuticals, I .. rey G. Proctor, M.D. to Scientific Advisory Board
[ 05:30 AM ] - Market Wire
Electro-Optical Sciences, Inc.: Electro-Optical S .. Data From MelaFind(R) Pivotal Study Presented at
Wed, March 11, 2009
[ 12:23 PM ] - Market Wire
Molecular Insight Pharmaceuticals, Inc. : Molecul .. Protocol Assessment Approval From FDA for Phase 2
[ 06:00 AM ] - Market Wire
PDL BioPharma: PDL BioPharma Elects Frederick Frank and Jody Lindell to Its Board of Directors
[ 04:30 AM ] - Market Wire
DUSA Pharmaceuticals, Inc.: DUSA Pharmaceuticals .. ll Year 2008 Corporate Highlights and Financial R
Tue, March 10, 2009
[ 02:00 PM ] - Market Wire
Watson Pharmaceuticals: Watson to Present at Cowen and Company 29th Annual Health Care Conference
[ 09:39 AM ] - Market Wire
Trinity Biotech: Trinity Biotech Announces Quarter 4 Results
[ 06:30 AM ] - Market Wire
Allana Resources Inc.: Allana Resources Appoints .. a Biya Senior Vice President Business Development
[ 06:15 AM ] - Market Wire
AVI BioPharma, Inc.: AVI BioPharma Announces Fourth Quarter and Year End 2008 Financial Results
[ 06:00 AM ] - Market Wire
Vyteris, Inc.: Vyteris Initiates Phase II Clinica .. nfertility Treatment Using Smart Patch Technology
[ 05:00 AM ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. en and Company 29th Annual Health Care Conference
[ 05:00 AM ] - Market Wire
Eurand N.V.: FDA Grants Orphan Drug Designation for EUR-1073
Mon, March 9, 2009
[ 02:08 PM ] - Market Wire
Facet Biotech: Facet Biotech Announces March 16 W .. Full Year 2008 Financial Results Conference Call
[ 08:00 AM ] - Market Wire
Pacific Energy Resources Ltd.: Pacific Energy Res .. iles for Chapter 11 to Facilitate a Restructuring
[ 07:50 AM ] - Market Wire
Trinity Biotech: Trinity Biotech Announces Commencement of TRI-stat(TM) CLIA Trials
[ 07:00 AM ] - Market Wire
Biomoda, Inc.: Biomoda Approved to Begin Screening Veterans for Lung Cancer
[ 06:30 AM ] - Market Wire
Electro-Optical Sciences, Inc.: Electro-Optical S .. on at the Cowen and Company 29th Annual Health Ca
[ 06:30 AM ] - Market Wire
PDL BioPharma: PDL BioPharma to Present at the Co .. h Annual Health Care Conference on March 18, 2009

PDL BioPharma: PDL BioPharma to Present at the Cowen and Company 29th Annual Health Care Conference on March 18, 2009


Published on 2009-03-09 06:35:15, Last Modified on 2009-03-09 06:35:40 - Market Wire
  Print publication without navigation


INCLINE VILLAGE, NV--(Marketwire - March 9, 2009) - PDL BioPharma, Inc. (PDL) (NASDAQ: [ PDLI ]) today announced that John P. McLaughlin, President & CEO, will present at the Cowen and Company 29th Annual Health Care Conference in Boston on Wednesday, March 18, at 8:45am Eastern time.

A live webcast of the presentation will be available through the PDL website: [ www.pdl.com ]. Please connect to this website at least 15 minutes prior to the live webcast to allow time for any software download that may be needed to hear the webcast. A replay will be available at [ www.pdl.com ] starting approximately one hour after completion of the webcast.

About PDL BioPharma

PDL BioPharma, Inc. pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and autoimmune diseases. This press release and further information about PDL BioPharma, Inc. can be found at: [ www.pdl.com ].

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

Contributing Sources